J&J beat quarterly sales and profit estimates on cancer drug sales
By Patrick Wingrove and Bhanvi Satija (Reuters) – Johnson & Johnson (J.N.J), fresh off a $14.6 billion deal to buy ...
Read more
JM Smucker predicts annual profit on inelastic demand, higher prices
(Reuters) – Jeff Peanut Butter maker JM Smucker (SJM) raised its annual profit forecast and beat second-quarter estimates on Tuesday, ...
Read more
